**ArteraAI** is revolutionizing cancer care with **personalized precision medicine** powered by **AI-driven therapy predictions**. Their flagship **ArteraAI Prostate Test** helps doctors tailor treatments for prostate cancer patients by analyzing biopsy images and clinical data—no extra tissue needed.

What are the features of Artera?

* **Multimodal AI Analysis**: Combines **digital pathology images** and **clinical data** for accurate predictions. * **Predicts Treatment Benefit**: Identifies which patients will respond best to **therapy intensification**. * **Fast Results**: Delivers **personalized reports** in **2-3 days**. * **Diverse Data Validation**: Trained on cohorts with **20% African American patients** for broader applicability. * **NCCN Guidelines® Recommended**: The **only AI test** endorsed for **prostate cancer treatment decisions**.

What are the use cases of Artera?

* **Localized Prostate Cancer**: Guides whether to **intensify or de-escalate therapy**. * **High-Risk Patients**: Helps identify those who need **more aggressive treatment**. * **Shared Decision-Making**: Gives **doctors and patients** clearer insights for **personalized care**.

1. **Order the Test**: Clinicians request the **ArteraAI Prostate Test** for eligible patients. 2. **Submit Samples**: Send existing **biopsy slides**—no new tissue required. 3. **Receive Results**: Get **AI-generated insights** within **2-3 days**. 4. **Plan Treatment**: Use the report to **personalize therapy options**.

**How does ArteraAI’s test work?**

It analyzes **digitized biopsy slides** and clinical data using AI to predict **treatment response and prognosis**.

**Is the test covered by insurance?**

Yes, **Medicare** covers the ArteraAI Prostate Test, and other insurers may follow.

**Does the test consume patient tissue?**

No, it uses **existing biopsy slides**, so no extra tissue is needed.

**Why is diversity in data important?**

African American men face **higher prostate cancer risks**, so inclusive data ensures **accurate predictions for all**.

Artera

3.0

98.01%

ArteraAI uses cutting-edge AI to personalize prostate cancer therapy, delivering fast, precise insights without extra biopsies. Trusted by NCCN Guidelines®, it’s a game-changer for doctors and patients.

Added on: 2025.07.09

Social Media:

#Health

Visit Site

Share This Tool: